Advertisement
Age of onset for disease is an important factor affecting clinical outcomes across the life span in patients receiving disease-modifying therapy for multiple sclerosis

Age of Onset May Affect Clinical Outcomes for MS Patients on DMT

0
Age-dependent differences seen for clinical outcomes in response to disease-modifying therapy
Vice President Mike Pence will lead the U.S. response to a potential global pandemic of COVID-19

First U.S. Case of ‘Unknown Origin’ COVID-19 Identified

0
President Trump taps Vice President Pence to head coronavirus response
Antibiotics and opioids are frequently prescribed during emergency department visits for dental conditions

Antibiotic, Opioid Rx Common With ED Visits for Dental Conditions

0
Authors say there is an opportunity to further combat opioid abuse, antibiotic overprescribing
For patients with refractory chronic cough or unexplained chronic cough

Gefapixant Promising for Relief of Unexplained Chronic Cough

0
Cough frequency significantly reduced after 12 weeks of gefapixant 50 mg versus placebo in phase 2b study
The incidence rates of tetanus and diphtheria are not significantly lower in countries that routinely vaccinate adults for these diseases

Adults May Not Need Tetanus, Diphtheria Booster Shots

0
No significant decrease seen in incidence rates of tetanus, diphtheria with routine vaccination of adults
Misleading ads about products that claim to cure or protect against the new coronavirus will be banned from Facebook

Facebook Bans False or Alarming Coronavirus Ads

0
The Center for Science in the Public Interest warns consumers to be cautious
In an American College of Rheumatology guideline

Reproductive Health Guidelines Issued for Rheumatic Diseases

0
Evidence reviewed for contraception, fertility, pregnancy, HRT, medication use in RMD patients
In a EuroNet Pediatric Hodgkin Lymphoma Group guideline

Recommendations Issued for R/R Pediatric Hodgkin Lymphoma

0
Recommendations developed for salvage therapy for pediatric patients with first relapse/refractory cHL
For middle-aged and older adults at high cardiovascular risk without diabetes

Intensive BP Control Has Positive Impact on Residual Life Span

0
Mean survival benefits varied from six months to three years for intensive versus standard BP control
Public opinion about the Affordable Care Act remains divided 10 years after its passage

Influence of Politics Has Not Waned in Opinions About ACA

0
Partisan divisions in favorable opinion of the ACA have gotten larger rather than smaller over time